Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Change in Cash: 2011-2025

Historic Change in Cash for Aytu Biopharma (AYTU) over the last 15 years, with Jun 2025 value amounting to $10.9 million.

  • Aytu Biopharma's Change in Cash rose 1545.10% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.5 million, marking a year-over-year increase of 8595.83%. This contributed to the annual value of $10.9 million for FY2025, which is 467.44% up from last year.
  • As of FY2025, Aytu Biopharma's Change in Cash stood at $10.9 million, which was up 467.44% from -$3.0 million recorded in FY2024.
  • Aytu Biopharma's Change in Cash's 5-year high stood at $10.9 million during FY2025, with a 5-year trough of -$30.5 million in FY2022.
  • Moreover, its 3-year median value for Change in Cash was $3.6 million (2023), whereas its average is $3.9 million.
  • Per our database at Business Quant, Aytu Biopharma's Change in Cash slumped by 2,047.77% in 2022 and then spiked by 467.44% in 2025.
  • Over the past 5 years, Aytu Biopharma's Change in Cash (Yearly) stood at $1.6 million in 2021, then crashed by 2,047.77% to -$30.5 million in 2022, then skyrocketed by 111.87% to $3.6 million in 2023, then slumped by 182.18% to -$3.0 million in 2024, then skyrocketed by 467.44% to $10.9 million in 2025.